EBOS Group Limited ( (AU:EBO) ) has provided an update.
EBOS Group Limited has announced the opening of a non-underwritten retail offer to raise up to A$50 million, as part of its equity raising efforts. This initiative follows a fully underwritten placement of new shares that raised approximately A$200 million, aimed at funding the acquisition of SVS and the remaining 10% stake in Transmedic, while also enhancing balance sheet capacity. The retail offer allows eligible shareholders in New Zealand and Australia to subscribe for new shares, which will be issued at the lower of the placement price or the five-day VWAP of EBOS shares. This strategic move is expected to strengthen EBOS’s market position and provide shareholders with an opportunity for pro rata allocation.
More about EBOS Group Limited
EBOS Group Limited is the largest and most diversified Australasian marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products. It is also a leading Australasian animal care brand owner, product marketer, and distributor.
YTD Price Performance: 2.21%
Average Trading Volume: 50,878
Technical Sentiment Signal: Sell
Current Market Cap: A$6.68B
Learn more about EBO stock on TipRanks’ Stock Analysis page.